What Does Bioidentical HRT Mean?

A pharmacy can dispense an approved estradiol patch or a custom-made estradiol cream. Both may contain a bioidentical hormone. The finished products have different evidence, manufacturing requirements, delivery methods, and instructions. Read the medicine's actual name and formulation before judging a claim about bioidentical treatment.

ACOG lists estradiol and micronized progesterone among commercially available approved bioidentical treatments. You can discuss these options with a prescriber without choosing a custom mixture.

Compounding can meet a need that an available manufactured product cannot meet. Examples include an allergy to an inactive ingredient or difficulty using an available formulation. The reason should be specific to the patient and recorded in the prescription plan.

ACOG gives progesterone containing peanut oil as an example: a patient with a relevant allergy may need a different preparation. A pharmacist and prescriber should first check the ingredients and suitable available alternatives. Different manufacturers can use different inactive ingredients.

For routine menopause treatment, ACOG recommends approved formulations when suitable ones exist. Research has not established that custom-compounded bioidentical hormone therapy is safer or more effective. FDA describes concerns about contamination, inconsistent strength, and incomplete labeling in compounded drugs. These concerns matter even when the active hormone is familiar.

Long-term evidence is especially limited. Short studies of symptoms or blood markers cannot establish the risk of breast cancer, endometrial cancer, or cardiovascular disease over years of use.

Some programs sell repeated saliva or urine hormone tests alongside custom treatment. ACOG does not recommend adjunct hormone tests to prescribe or dose compounded menopause therapy. Saliva measurements have problems with accuracy and do not reliably represent hormone effects within tissues.

For most patients, a menopause prescription is adjusted using symptom relief, side effects, bleeding, and the clinical assessment. A clinician may order a blood test for a specific diagnostic or safety question. Routine test packages have not established an ideal hormone level for each patient's menopause treatment.

Before paying for testing, ask what the result will change. A useful explanation names the condition being assessed, the limits of the measurement, and the next step if the result is abnormal.

Systemic estrogen can relieve hot flashes and night sweats. A person with a uterus generally needs adequate progestogen protection because estrogen alone can stimulate the uterine lining and increase endometrial cancer risk. Calling a cream bioidentical does not establish that its progesterone component provides enough protection.

Route, dose, duration, and medical history still affect the decision. Discuss previous blood clots, stroke, breast cancer, liver disease, and unexplained vaginal bleeding. An estradiol patch and an oral estrogen product can have different clot-risk profiles; the bioidentical label does not explain those differences.

Pellets need a separate conversation. Implanted hormones are designed to release over time, making prompt dose changes difficult. ACOG advises against testosterone pellets for menopause care because safety data are limited and the pellet is not designed for removal. Testosterone can cause acne, increased facial hair, and voice changes.

• What are the active hormones, doses, and delivery method?
• Is this exact product FDA-approved? If it is compounded, what medical need requires it?
• If I have a uterus, how will the prescription protect the uterine lining?
• What benefit should I expect, and when will we review symptoms and bleeding?
• How can treatment be adjusted or stopped if side effects occur?

Bring the ingredient list and dispensing label if you already use a compounded preparation. Knowing whether it contains estradiol, estriol, progesterone, testosterone, or several hormones helps the clinician assess exposure and plan any change. In the United States, FDA has approved no estriol-containing drug; availability and regulatory status differ in other countries.